Liquid biopsies in patients with diffuse glioma

Keyphrases

• Liquid Biopsy 100%
• Diffuse Glioma 100%
• Glioma 66%
• Patient Management 66%
• Tumor 33%
• Clinical Trials 33%
• Molecular Characteristics 33%
• Predictive Biomarker 33%
• Treatment Monitoring 33%
• Primary Tumor 33%
• Tumor Heterogeneity 33%
• Circulating Tumor Cells 33%
• Glioma Patients 33%
• Central Nervous System Tumors 33%
• Neoplasms 33%
• Delayed Diagnosis 33%
• Molecular Information 33%
• Cerebrospinal Fluid 33%
• Blood Platelets 33%
• Platelets 33%
• Tumor Samples 33%
• Molecular Biomarkers 33%
• Blood Biomarkers 33%
• Serial Monitoring 33%
• Nucleic Acids 33%
• Circulating Cells 33%
• Serum Blood 33%
• Circulating Molecules 33%
• Circulating Vesicles 33%
• Tumor-derived Extracellular Vesicles 33%
• Sampling Error 33%

Medicine and Dentistry

• Ganglioglioma 100%
• Liquid Biopsy 100%
• Biological Marker 66%
• Neoplasm 50%
• Platelet 33%
• Clinical Trial 16%
• Primary Tumor 16%
• Diagnosis 16%
• Treatment Response 16%
• Circulating Tumor Cell 16%
• Central Nervous System 16%
• Patient Care 16%
• Cerebrospinal Fluid 16%
• Tumour Heterogeneity 16%
• Nucleic Acid 16%

Immunology and Microbiology

• Platelet 100%
• Blood Plasma 50%
• Central Nervous System 50%
• Cerebrospinal Fluid 50%
• Circulating Tumor Cell 50%
• Serum (Blood) 50%